Section 522.1850 - Polysulfated glycosaminoglycan(a)Specifications.(1) Each 1-milliliter (mL) ampule of solution contains 250 milligrams (mg) polysulfated glycosaminoglycan.(2) Each mL of solution packaged in 5-mL ampules or 20-, 30-, or 50-mL vials contains 100 mg polysulfated glycosaminoglycan.(b)Sponsor. See No. 010797 in § 510.600(c) of this chapter.(c)Special considerations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.(d)Conditions of use - (1)Horses - (i)Indications for use. For the treatment of noninfectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.(ii)Amount - (A)Intra-articular use (carpal) : 250 mg once a week for 5 weeks.(B)Intramuscular use (carpal and hock) : 500 mg every 4 days for 28 days.(iii)Limitations. Do not use in horses intended for human consumption.(2)Dogs - (i)Indications for use. For control of signs associated with noninfectious degenerative and/or traumatic arthritis of canine synovial joints.(ii)Amount. 2 mg per pound of body weight by intramuscular injection twice weekly for up to 4 weeks (maximum of 8 injections). 72 FR 56896 , Oct. 5, 2007, as amended at 74 FR 67816 , Dec. 21, 2009